Share your experiences of supervising postgraduate research degree students
The UK Research Supervision Survey (UKRSS) is a national survey, run by the UK Council for Graduate Education, providing those involved in research supervision an opportunity to share their experiences of supervising PGRs.
The survey is open to all those involved in supervising PGRs enrolled at a UK HEI, whether they are supervising in a formal or informal capacity, partly based in industry, or located somewhere other than the UK.
The findings will form a report to help the UKCGE and the wider postgraduate community better understand the complexity of contemporary research supervision and how it is recognised and rewarded.
How do I take part?
The survey takes approximately 15 minutes to complete with an opportunity to win £250 for taking part.
To share your experiences of supervising PGRs:
The survey closes on 31st May 2021.
Why should I take part?
Despite its importance and complexity, research supervision is often an undervalued area of academic practice. With support from Wellcome Trust and UKRI, this survey is another important part of the UKCGE’s support for those involved in research supervision and will help to build the clearest picture of contemporary research supervision in the UK.
More information
You can find out more information about the survey on the UKCGE website.
Postgraduate Research Experience Survey (PRES) now open










Beyond Academia: Exploring Career Options for Early Career Researchers – Online Workshop
UKCGE Recognised Research Supervision Programme: Deadline Approaching
SPROUT: From Sustainable Research to Sustainable Research Lives
BRIAN upgrade and new look
Seeing the fruits of your labour in Bangladesh
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease